blank
blank

Example of costing of Clinical Trial Budget

1:1
Budget example showing low and high cost ranges for a Phase 1 rare disease clinical trial with twenty subjects.

Budget example providing low and high cost estimates for a Phase 1 clinical trial with 20 subjects, broken down by workstreams including study design and protocol, regulatory affairs, project management, investigator sites, patient recruitment and retention, genomics component, clinical data management, monitoring and pharmacovigilance, investigational medicinal product costs, statistics and publication, and institutional overheads. It includes subtotal and total ranges and a cost-per-patient estimate.

Acces this publication
blank

publication

ERDERA CTC 2026

Year of publication

2026

Source

European Rare Diseases Research Alliance (ERDERA)

Author

You might also be interested in

ECRD 2026

ECRD 2026 in Prague strengthens the push for a coordinated EU Action Plan on rare diseases

On 3–4 June, EURORDIS–Rare Diseases Europe and Orphanet convened the rare disease community at ECRD 2026 in Prague around a shared call for coordinated European action, including the forthcoming European Blueprint for Rare Diseases.

Understanding ERDERA: Europe’s alliance for rare disease research

30 million people in Europe live with a rare disease. Yet most still lack a diagnosis or treatment. So what is ERDERA doing about it?
European Biotech Act 062026

ERDERA Policy Brief: European Biotech Act

The European Rare Diseases Research Alliance (ERDERA), together with the European Reference Networks (ERNs), provides the missing operational layer required to implement the European Biotech Act across the full innovation pathway —from discovery to patient access.
ERDERA JTC 2026 (1)

ERDERA Clinical Trial Call 2026 – Information Webinar

July 6 @ 3:00 pm - 5:00 pm

ERDERA's

search form